Valuation
Biotech Valuation
ARiDA runs evidence-backed biotech valuation workflows across single assets, multi-asset portfolios, platforms, fundraises, real options, Monte Carlo risk, and board dossiers.
A valuation workspace for teams that need assumptions, evidence, model outputs, and board language to stay connected.
Open solution